
A recent celebrity endorsement for the postpartum depression drug Zerzovay could create a near-term catalyst for its developers, Sage Therapeutics (SAGE) and Biogen (BIIB). This organic, high-profile mention may significantly boost public awareness and drive initial sales for the new treatment. For long-term investors, the value of strong intellectual property in media remains a key theme. Companies like Lionsgate (LGF.A) with The Hunger Games and Disney (DIS) with its Marvel franchises demonstrate the power of repeatable content. Consider these media giants for their durable IP-driven revenue streams.

By The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp